Stocks / AMEX / Mast Therapeutics, Inc.

Mast Therapeutics, Inc.

Our Opinion

Mast Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.


“Last week, the company announced positive data from nonclinical studies in testing vepoloxamer on animals with severe heart failure.”

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. [Source: MarketWatch]